BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37657688)

  • 1. Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications.
    Dutta P; Pal D; Roy A; Mandal RK; Panda CK
    Gene; 2023 Dec; 888():147746. PubMed ID: 37657688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed During the Development of Chemo-tolerance: Clinical Implications.
    Dutta P; Pal D; Sultana F; Mandal RK; Roy A; Panda CK
    Reprod Sci; 2024 Apr; 31(4):1122-1138. PubMed ID: 38012520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
    Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK
    Mol Cell Biochem; 2023 Jul; 478(7):1599-1610. PubMed ID: 36434146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of P16-RBSP3 inactivation with phosphorylated RB1 overexpression in basal-parabasal layers of normal cervix unchanged during CACX development.
    Chakraborty C; Roychowdhury A; Samadder S; Roy A; Mandal RK; Basu P; Roychoudhury S; Panda CK
    Biochem J; 2016 Oct; 473(19):3221-36. PubMed ID: 27458253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Wnt-β-catenin pathway in basal-parabasal layers of normal cervical epithelium comparable during development of uterine cervical carcinoma.
    Chakraborty C; Samadder S; Roychowdhury A; Roy A; Das P; Mandal RK; Roychoudhury S; Panda CK
    Mol Cell Biochem; 2018 Jun; 443(1-2):121-130. PubMed ID: 29079964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
    Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
    Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.
    Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M
    Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W; Wang LQ; Liu Y; Liu AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
    [No Abstract]   [Full Text] [Related]  

  • 9. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
    Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
    Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of LIMD1-VHL-HIF-1α-VEGF pathway is associated with different stages of cervical cancer.
    Chakraborty C; Mitra S; Roychowdhury A; Samadder S; Dutta S; Roy A; Das P; Mandal RK; Sharp TV; Roychoudhury S; Panda CK
    Biochem J; 2018 May; 475(10):1793-1806. PubMed ID: 29654110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between promoter methylation of MLH1 and MSH2 and reactive oxygen species in oligozoospermic men-A pilot study.
    Gunes S; Agarwal A; Henkel R; Mahmutoglu AM; Sharma R; Esteves SC; Aljowair A; Emirzeoglu D; Alkhani A; Pelegrini L; Joumah A; Sabanegh E
    Andrologia; 2018 Apr; 50(3):. PubMed ID: 28983945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylation of mismatch repair genes MLH1 and MSH2 is associated with chemotolerance of breast carcinoma: Clinical significance.
    Dasgupta H; Islam S; Alam N; Roy A; Roychoudhury S; Panda CK
    J Surg Oncol; 2019 Jan; 119(1):88-100. PubMed ID: 30481381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer.
    Haron NH; Mohamad Hanif EA; Abdul Manaf MR; Yaakub JA; Harun R; Mohamed R; Mohamed Rose I
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):509-517. PubMed ID: 30803214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential association of hedgehog pathway in development of cervical carcinoma and its chemo-tolerance.
    Pal D; Samadder S; Dutta P; Roychowdhury A; Chakraborty B; Dutta S; Roy A; Mandal RK; Panda CK
    Pathol Res Pract; 2023 Aug; 248():154696. PubMed ID: 37516000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair.
    DuPrie ML; Palacio T; Calil FA; Kolodner RD; Putnam CD
    DNA Repair (Amst); 2022 Nov; 119():103405. PubMed ID: 36122480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressional analysis of MLH1 and MSH2 in breast cancer.
    Malik SS; Masood N; Asif M; Ahmed P; Shah ZU; Khan JS
    Curr Probl Cancer; 2019 Apr; 43(2):97-105. PubMed ID: 30149959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
    Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
    [No Abstract]   [Full Text] [Related]  

  • 18. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.
    Mitra S; Mazumder Indra D; Bhattacharya N; Singh RK; Basu PS; Mondal RK; Roy A; Zabarovsky ER; Roychoudhury S; Panda CK
    Genes Chromosomes Cancer; 2010 Feb; 49(2):155-70. PubMed ID: 19885927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair and treatment resistance in ovarian cancer.
    Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM
    BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of DNA repair genes MLH1 and MSH2 in adenocarcinomas and squamous cell carcinomas of the lung.
    Gomes A; Reis-Silva M; Alarcão A; Couceiro P; Sousa V; Carvalho L
    Rev Port Pneumol; 2014; 20(1):20-30. PubMed ID: 24360395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.